PVI
IMCR icon

Pura Vida Investments’s Immunocore IMCR Stock Holding History

Pura Vida Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,419
Closed -$239K – 227
2022
Q2 		$239K Buy
+6,419
New +$208K 0.01% 187
2022
Q1 		– Sell
-19,071
Closed -$653K – 252
2021
Q4 		$653K Sell
19,071
-30,929
-62% -$1.12M 0.02% 201
2021
Q3 		$1.85M Buy
+50,000
New +$1.69M 0.06% 194

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Pura Vida Investments's IMCR Position: Q3 2022 in Review

Pura Vida Investments sold out of Immunocore (IMCR) in Q3 2022, closing a stake of 6,419 shares — an estimated $239K sold.

Pura Vida Investments first reported a position in IMCR in Q3 2021 and held it in 3 quarters. The position peaked at $1.85M in Q3 2021. 86 funds tracked by Wall St. Rank hold IMCR as of Q3 2022.

  • Pura Vida Investments reported no remaining Immunocore position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 6,419 Immunocore shares in Q3 2022, an estimated $239K.
  • Pura Vida Investments first reported a position in Immunocore in Q3 2021 and held it in 3 quarters.
  • Pura Vida Investments's Immunocore position peaked at $1.85M in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Immunocore as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.